Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuromuscular Disorders"
DOI: 10.1016/j.nmd.2019.06.002
Abstract: Rituximab is a chimeric monoclonal antibody that binds CD20 and causes the depletion of B-cell subsets. Although initially designed to treat lymphoma, it has found wide use in the management of various autoimmune conditions, including…
read more here.
Keywords:
agents initiation;
stopping oral;
steroid sparing;
oral steroid ... See more keywords